ETILX vs. ETIHX

Last updated Jun 5, 2026

ETILX (Eventide Gilead Class I) and ETIHX (Eventide Healthcare & Life Sciences Fund) are both mutual funds - ETILX is a Mid Cap Growth Equities fund managed by Eventide Funds, while ETIHX is a Health & Biotech Equities fund managed by Eventide Funds. Over the past 10 years, ETILX returned 13.80%/yr vs 11.89%/yr for ETIHX. A 0.77 correlation means they provide meaningful diversification when combined. ETILX charges 1.11%/yr vs 1.30%/yr for ETIHX.

Performance

ETILX vs. ETIHX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Eventide Gilead Class I (ETILX) and Eventide Healthcare & Life Sciences Fund (ETIHX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ETILX achieves a 13.33% return, which is significantly higher than ETIHX's -6.48% return. Over the past 10 years, ETILX has outperformed ETIHX with an annualized return of 13.80%, while ETIHX has yielded a comparatively lower 11.89% annualized return.

ETILX

• 1D: -0.46%
• 1M: 8.22%
• YTD: 13.33%
• 6M: 11.73%
• 1Y: 33.69%
• 3Y*: 15.64%
• 5Y*: 4.39%
• 10Y*: 13.80%

ETIHX

• 1D: 1.02%
• 1M: -7.57%
• YTD: -6.48%
• 6M: -7.55%
• 1Y: 48.58%
• 3Y*: 9.06%
• 5Y*: 3.34%
• 10Y*: 11.89%

*Multi-year figures are annualized to reflect compound growth (CAGR)

ETILX vs. ETIHX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ETILX Eventide Gilead Class I	13.33%	23.77%	-0.03%	22.76%	-34.03%	11.44%	55.44%	34.11%	-2.35%	33.09%
ETIHX Eventide Healthcare & Life Sciences Fund	-6.48%	56.73%	-10.13%	11.01%	-19.62%	-16.87%	37.12%	58.74%	-0.27%	45.83%

Correlation

The correlation between ETILX and ETIHX is 0.60, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.60
Correlation (3Y) Calculated over the trailing 3-year period	0.71
Correlation (5Y) Calculated over the trailing 5-year period	0.72
Correlation (10Y) Calculated over the trailing 10-year period	0.75
Correlation (All Time) Calculated using the full available price history since Jan 3, 2013	0.77

The correlation between ETILX and ETIHX shifts across timeframes, from 0.60 (1 year) to 0.77 (all time), reflecting how their relationship changes across market environments.

Return for Risk

ETILX vs. ETIHX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ETILX

ETILX Risk / Return Rank: 42
ETILX Sharpe Ratio Rank: 44
ETILX Sortino Ratio Rank: 40
ETILX Omega Ratio Rank: 41
ETILX Calmar Ratio Rank: 39
ETILX Martin Ratio Rank: 45

ETIHX

ETIHX Risk / Return Rank: 58
ETIHX Sharpe Ratio Rank: 50
ETIHX Sortino Ratio Rank: 45
ETIHX Omega Ratio Rank: 42
ETIHX Calmar Ratio Rank: 84
ETIHX Martin Ratio Rank: 68

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ETILX vs. ETIHX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Eventide Gilead Class I (ETILX) and Eventide Healthcare & Life Sciences Fund (ETIHX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ETILX	ETIHX	Difference
Sharpe ratio: Return per unit of total volatility	1.92	2.08	-0.16
Sortino ratio: Return per unit of downside risk	2.64	2.81	-0.17
Omega ratio: Gain probability vs. loss probability	1.34	1.35	0.00
Calmar ratio: Return relative to maximum drawdown	2.36	3.94	-1.59
Martin ratio: Return relative to average drawdown	9.39	13.14	-3.74
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ETILX vs. ETIHX - Sharpe Ratio Comparison

The current ETILX Sharpe Ratio is 1.92, which is comparable to the ETIHX Sharpe Ratio of 2.08. The chart below compares the historical Sharpe Ratios of ETILX and ETIHX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	ETILX	ETIHX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.92	2.08	-0.16
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.18	0.12	+0.06
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.59	0.42	+0.17
Sharpe Ratio (All Time) Calculated using the full available price history	0.59	0.51	+0.08

Drawdowns

ETILX vs. ETIHX - Drawdown Comparison

The maximum ETILX drawdown since its inception was -41.30%, smaller than the maximum ETIHX drawdown of -55.11%. Use the drawdown chart below to compare losses from any high point for ETILX and ETIHX.

Drawdown Indicators

	ETILX	ETIHX	Difference
Max Drawdown Largest peak-to-trough decline	-41.30%	-55.11%	+13.81%
Max Drawdown (1Y) Largest decline over 1 year	-14.40%	-12.50%	-1.90%
Max Drawdown (3Y) Largest decline over 3 years	-25.71%	-33.23%	+7.52%
Max Drawdown (5Y) Largest decline over 5 years	-41.30%	-49.27%	+7.97%
Max Drawdown (10Y) Largest decline over 10 years	-41.30%	-55.11%	+13.81%
Current Drawdown Current decline from peak	-0.49%	-9.94%	+9.45%
Average Drawdown Average peak-to-trough decline	-11.52%	-17.98%	+6.46%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.61%	3.74%	-0.13%

Volatility

ETILX vs. ETIHX - Volatility Comparison

The current volatility for Eventide Gilead Class I (ETILX) is 5.16%, while Eventide Healthcare & Life Sciences Fund (ETIHX) has a volatility of 9.64%. This indicates that ETILX experiences smaller price fluctuations and is considered to be less risky than ETIHX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ETILX	ETIHX	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.16%	9.64%	-4.48%
Volatility (6M) Calculated over the trailing 6-month period	14.30%	18.82%	-4.52%
Volatility (1Y) Calculated over the trailing 1-year period	17.73%	23.73%	-6.00%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	24.22%	27.85%	-3.63%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	23.43%	28.40%	-4.97%

ETILX vs. ETIHX - Expense Ratio Comparison

ETILX has a 1.11% expense ratio, which is lower than ETIHX's 1.30% expense ratio.

Dividends

ETILX vs. ETIHX - Dividend Comparison

ETILX's dividend yield for the trailing twelve months is around 10.65%, while ETIHX has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ETIHX Eventide Healthcare & Life Sciences Fund	0.00%	0.00%	0.00%	0.00%	0.00%	10.78%	3.49%	2.08%	7.33%	1.28%	0.00%	1.22%
ETILX Eventide Gilead Class I	10.65%	12.07%	1.25%	0.00%	5.36%	6.30%	0.79%	3.14%	5.31%	0.00%	0.00%	1.13%

Frequently Asked Questions

Can I hold both ETILX and ETIHX in my portfolio?

ETILX and ETIHX have a correlation of 0.60, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ETILX or ETIHX?

ETIHX has higher volatility (9.64%) compared to ETILX (5.16%). In terms of maximum drawdown, ETILX dropped -41.30% vs ETIHX's -55.11%.

Which has better risk-adjusted returns?

ETIHX currently has the higher Sharpe Ratio (2.08 vs 1.92), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.